TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15607618

Group type: EXPERIMENTAL
Intervention: cerivastatin (0.3 mg/day)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: candesartan (8 mg/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (24 normocholesterolemic subjects without any therapy)
Number of subjects: 24
Study: 11282864

Group type: EXPERIMENTAL
Intervention: Antidepressant drugs
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Generic counselling
Number of subjects: 323

Group type: COMPARATOR
Intervention: Randomised arms (both interventions)
Number of subjects: 323

Group type: COMPARATOR
Intervention: Overall assessment by psychiatrist
Number of subjects: 323

Group type: COMPARATOR
Intervention: Overall remission
Number of subjects: 323

Group type: COMPARATOR
Intervention: Relapse
Number of subjects: 323
Study: 9291700

Group type: EXPERIMENTAL
Intervention: Family caregivers' assessments of patients' symptom distress
Number of subjects: 37

Group type: COMPARATOR
Intervention: Patients' self-reports of symptom distress
Number of subjects: 37
Study: 8445152

Group type: COMPARATOR
Intervention: 50 mU biosynthetic human growth hormone (r‐hGH) bolus
Number of subjects: 11

Group type: COMPARATOR
Intervention: 80 mU/h iv infusion of r‐hGH
Number of subjects: 11

Group type: COMPARATOR
Intervention: 500 mU r‐hGH bolus
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: GHRH (1‐29) NH2 (100 micrograms)
Number of subjects: 11
Study: 3813608

Group type: EXPERIMENTAL
Intervention: 2000 IU vitamin D supplementation
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 1000 IU vitamin D supplementation
Number of subjects: 49

Group type: COMPARATOR
Intervention: No vitamin D supplementation (control group 3)
Number of subjects: 49

Group type: COMPARATOR
Intervention: 400 IU vitamin D supplementation for infants
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Maternal supplementation with 2000 IU of vitamin D
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Maternal supplementation with 1000 IU of vitamin D
Number of subjects: 49
Study: 29308949

Group type: EXPERIMENTAL
Intervention: Mobilization with movements (MWMs)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Passive joint mobilization (PJM)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Electrotherapy
Number of subjects: 72
Study: 26674087

Group type: EXPERIMENTAL
Intervention: Self-management group intervention
Number of subjects: 24

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 24
Study: 24419019

Group type: EXPERIMENTAL
Intervention: Electromyography-triggered neuromuscular stimulation and mirror therapy (ETMS-MT)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Delayed ETMS-MT
Number of subjects: 13
Study: 22404531

Group type: EXPERIMENTAL
Intervention: Suprapubic cystostomy
Number of subjects: 65

Group type: COMPARATOR
Intervention: Urethral Foley catheter
Number of subjects: 65
Study: 20495788

Group type: EXPERIMENTAL
Intervention: Acute tyrosine and phenylalanine depletion (ATPD)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 18562328

Group type: EXPERIMENTAL
Intervention: Anthracycline-docetaxel-based sequential or concurrent chemotherapy
Number of subjects: 2887

Group type: COMPARATOR
Intervention: Anthracycline-based adjuvant chemotherapy
Number of subjects: 2887

Group type: EXPERIMENTAL
Intervention: Docetaxel-treated patients
Number of subjects: 2887
Study: 15650663

Group type: EXPERIMENTAL
Intervention: TransFix cross‐pin fixation
Number of subjects: 62

Group type: COMPARATOR
Intervention: Metal interference screw fixation
Number of subjects: 62
Study: 12437859

Group type: EXPERIMENTAL
Intervention: Enhanced care patients received bimonthly protective treatment and twice-daily chlorhexidine mouthrinses to treat gingivitis
Number of subjects: 376

Group type: COMPARATOR
Intervention: Control group subjects received professional dental protective treatment and checkups at baseline, 6 months, and 1 year, plus dental care
Number of subjects: 376
Study: 10851564

Group type: EXPERIMENTAL
Intervention: Low-dose fosinopril (10 mg/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7502497

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 47

Group type: COMPARATOR
Intervention: Open cholecystectomy
Number of subjects: 47
Study: 1952007

Group type: EXPERIMENTAL
Intervention: Neostigmine 15 micrograms/kg with glycopyrronium 3 micrograms/kg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Neostigmine 35 micrograms/kg with glycopyrronium 7 micrograms/kg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Neostigmine 55 micrograms/kg with glycopyrronium 11 micrograms/kg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Neostigmine 75 micrograms/kg with glycopyrronium 15 micrograms/kg
Number of subjects: 32
Study: 6316711

Group type: EXPERIMENTAL
Intervention: Ventilation tubes
Number of subjects: 150

Group type: COMPARATOR
Intervention: Intact ears (control)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Children with initial tonsillectomy
Number of subjects: 150
Study: 29788243

Group type: EXPERIMENTAL
Intervention: Social support (measured with the Multidimensional Scale of Perceived Social Support)
Number of subjects: 3496

Group type: EXPERIMENTAL
Intervention: Lifetime and past year victimization
Number of subjects: 3496
Study: 28461283

Group type: EXPERIMENTAL
Intervention: HERA (Health Evaluation and Referral Assistant)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: HERA (Health Evaluation and Referral Assistant) with faxed referral
Number of subjects: 212

Group type: COMPARATOR
Intervention: Minimal-treatment control
Number of subjects: 212
Study: 26691925

Group type: EXPERIMENTAL
Intervention: Peer feedback (PF)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Faculty feedback (FF)
Number of subjects: 24
Study: 25059927

Group type: EXPERIMENTAL
Intervention: AIS-GIB score (18-point scoring system based on independent predictors of GIB)
Number of subjects: 8820
Study: 22019112

Group type: EXPERIMENTAL
Intervention: Home blood pressure monitoring (HBPM) program
Number of subjects: 232

Group type: COMPARATOR
Intervention: Standard health intervention (Control group)
Number of subjects: 232
Study: 19290714

Group type: EXPERIMENTAL
Intervention: 24-month expert system intervention (SunSmart)
Number of subjects: 819

Group type: COMPARATOR
Intervention: Physical activity and nutrition comparison group
Number of subjects: 819
Study: 17360294

Group type: EXPERIMENTAL
Intervention: Clanging Tuning Fork (CTF) test
Number of subjects: 45

Group type: COMPARATOR
Intervention: 10-g Semmes-Weinstein monofilament test
Number of subjects: 45
Study: 15347374

Group type: EXPERIMENTAL
Intervention: Injective immunotherapy with a maintenance dose of 7.2 microg of Amb a 1 administered at 4-week intervals
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 11837227

Group type: EXPERIMENTAL
Intervention: Diet enriched in saturated fatty acids (SFA)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Diet enriched in carbohydrates (NCEP‐1)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Diet enriched in monounsaturated fatty acids (MUFA)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Saturated diet to either of the other diets (carbohydrates or MUFA)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Non-smoking carriers of the S2 allele
Number of subjects: 59
Study: 9566455

Group type: EXPERIMENTAL
Intervention: Intervention form with explicit decision-support tool
Number of subjects: 450

Group type: COMPARATOR
Intervention: Control form
Number of subjects: 450
Study: 7848670

Group type: EXPERIMENTAL
Intervention: Participant intervention (mailed reminder letter and refrigerator magnet)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physician intervention (mailed packet to participant's physician including letter, NCEP guidelines, and preaddressed postcard to mail to patient)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both interventions (participant and physician)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 0
Study: 2564262

Group type: EXPERIMENTAL
Intervention: Vecuronium 50 micrograms/kg iv as the only muscle relaxant
Number of subjects: 28

Group type: COMPARATOR
Intervention: Succinylcholine 1.5 mg/kg
Number of subjects: 28
Study: 29573047

Group type: EXPERIMENTAL
Intervention: Siblings Coping Together (SibCT)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Attention Control Group (CG)
Number of subjects: 70
Study: 28979957

Group type: EXPERIMENTAL
Intervention: Strawberry beverage prepared in milk
Number of subjects: 9

Group type: COMPARATOR
Intervention: Strawberry beverage prepared in water
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Strawberry beverage prepared in milk without meal
Number of subjects: 9

Group type: COMPARATOR
Intervention: Strawberry beverage prepared in water without meal
Number of subjects: 9
Study: 26563009

Group type: EXPERIMENTAL
Intervention: Quantum Molecular Resonance Tonsillectomy (QMRT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Blunt Dissection Tonsillectomy (BDT)
Number of subjects: 80
Study: 24946658

Group type: EXPERIMENTAL
Intervention: Upright body position
Number of subjects: 20

Group type: COMPARATOR
Intervention: Supine body position
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Higher percentages of maximum pressure
Number of subjects: 20
Study: 21439539

Group type: EXPERIMENTAL
Intervention: hs-CRP >2 mg/L and BMS
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: hs-CRP >2 mg/L and DES
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: hs-CRP ≤2 mg/L and BMS
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: hs-CRP ≤2 mg/L and DES
Number of subjects: 301

Group type: COMPARATOR
Intervention: BMS + CRP ≤2 mg/L
Number of subjects: 301
Study: 18237536

Group type: EXPERIMENTAL
Intervention: Specific allergen nebulization (group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline nebulization (group A)
Number of subjects: 40
Study: 16776767

Group type: EXPERIMENTAL
Intervention: New supported mandibular denture
Number of subjects: 18

Group type: COMPARATOR
Intervention: Old unsupported denture
Number of subjects: 18

Group type: COMPARATOR
Intervention: Magnet, ball, and bar-clip attachment types
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Implant treatment
Number of subjects: 18
Study: 15342835

Group type: EXPERIMENTAL
Intervention: CPAP/PEEP
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control (no CPAP/PEEP)
Number of subjects: 104
Study: 11264609

Group type: EXPERIMENTAL
Intervention: Vaginal hysterectomy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Laparoscopic assisted vaginal hysterectomy
Number of subjects: 80
Study: 9260735

Group type: EXPERIMENTAL
Intervention: Nifedipine (60 mg daily)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 8497701

Group type: EXPERIMENTAL
Intervention: Methotrexate 30 mg week-1
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 3497943

Group type: EXPERIMENTAL
Intervention: Commercial latex agglutination kits (Directigen, Bactigen) for S. pneumoniae antigens in serum
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Commercial latex agglutination kits (Directigen, Bactigen) for H. influenzae type b antigens in serum and urine
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Commercial latex agglutination kits (Directigen, Bactigen) for S. pneumoniae antigens in urine
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Commercial latex agglutination kits (Directigen, Bactigen) for H. influenzae type b pneumonia
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Commercial latex agglutination kits (Directigen, Bactigen) for S. pneumoniae pneumonia
Number of subjects: 44
Study: 29138275

Group type: EXPERIMENTAL
Intervention: 1-h blood glucose measurement (≥8.6 mmol/L)
Number of subjects: 4867

Group type: COMPARATOR
Intervention: 2-h blood glucose measurement (≥7.8 mmol/L)
Number of subjects: 4867

Group type: EXPERIMENTAL
Intervention: 1-h glucose measurement
Number of subjects: 4867
Study: 25814780

Group type: EXPERIMENTAL
Intervention: Open flap debridement (OFD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (periodontally healthy subjects)
Number of subjects: 30
Study: 23636241

Group type: EXPERIMENTAL
Intervention: Minced beef
Number of subjects: 10

Group type: COMPARATOR
Intervention: Beef steak
Number of subjects: 10
Study: 20886788

Group type: EXPERIMENTAL
Intervention: Electroacupuncture combined with western medicine (Simvastatin, Glipizide XL, Felodipine sustained-release tablets)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Western medicine only (Simvastatin, Glipizide XL, Felodipine sustained-release tablets)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Comparison between groups after treatment
Number of subjects: 80
Study: 18209515

Group type: EXPERIMENTAL
Intervention: Verum acupuncture (VA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham acupuncture (SA)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined VA and SA
Number of subjects: 30
Study: 17283935

Group type: EXPERIMENTAL
Intervention: Smelling group (odours were smelled)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Imagining group (odours were imagined)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Meaning group (odour source names were compared)
Number of subjects: 3
Study: 14625504

Group type: EXPERIMENTAL
Intervention: Soccer players
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (moderately active individuals)
Number of subjects: 23
Study: 10981087

Group type: EXPERIMENTAL
Intervention: Lowering diastolic blood pressure to levels below 80 mm Hg in patients with diabetes
Number of subjects: 19000

Group type: EXPERIMENTAL
Intervention: Low dose aspirin therapy in patients with hypertension
Number of subjects: 19000

Group type: COMPARATOR
Intervention: Reduction of diastolic blood pressure to less than 90 mm Hg
Number of subjects: 19000

Group type: EXPERIMENTAL
Intervention: Diastolic blood pressure of 83 mm Hg
Number of subjects: 19000
Study: 8877020

Group type: EXPERIMENTAL
Intervention: Metamizol 25 mg kg‐1
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Pethidine 0.4 mg kg‐1
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 1890910

Group type: EXPERIMENTAL
Intervention: Nicardipine (60‐120 mg daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Propranolol (120‐240 mg daily)
Number of subjects: 30
Study: 6366719

Group type: EXPERIMENTAL
Intervention: Cimetidine (600 mg/m2 body surface/day for 4 months)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 38
Study: 29266194

Group type: EXPERIMENTAL
Intervention: Conflictual discussion with marital partner
Number of subjects: 117

Group type: COMPARATOR
Intervention: Positive discussion with marital partner
Number of subjects: 117
Study: 30477842

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (25,000 IU/day for two months)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 150
Study: 26832632

Group type: EXPERIMENTAL
Intervention: Rehabilitation with visual stimuli using digital video disk (DVD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cawthorne‐Cooksey exercises
Number of subjects: 40
Study: 24170559

Group type: EXPERIMENTAL
Intervention: Multimedia educational program (15 minutes)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Educational literature
Number of subjects: 108
Study: 21345620

Group type: EXPERIMENTAL
Intervention: Forward-planned intensity-modulated radiotherapy (IMRT)
Number of subjects: 1145

Group type: COMPARATOR
Intervention: Standard radiotherapy (RT)
Number of subjects: 1145
Study: 20038244

Group type: COMPARATOR
Intervention: Fluconazole (1200 mg per day) alone
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Combination of fluconazole (1200 mg per day) and flucytosine (100 mg/kg per day) followed by fluconazole (800 mg per day)
Number of subjects: 41
Study: 17209957

Group type: EXPERIMENTAL
Intervention: Smartsuction (SS)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 54
Study: 15616799

Group type: EXPERIMENTAL
Intervention: High-Fat (HF) Atkins Diet
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: High-Protein (HP) Zone Diet
Number of subjects: 96

Group type: COMPARATOR
Intervention: High-Carbohydrate (HC) diet
Number of subjects: 96
Study: 12004166

Group type: EXPERIMENTAL
Intervention: Continuous low-level heat wrap therapy (40 C, 8 hours/day)
Number of subjects: 371
Study: 10442945

Group type: EXPERIMENTAL
Intervention: Salivary endotoxin concentration in pediatric leukemia patients
Number of subjects: 12

Group type: COMPARATOR
Intervention: Healthy children (control group)
Number of subjects: 12
Study: 8588015

Group type: EXPERIMENTAL
Intervention: Experimental referral procedure involving home visits by a community nurse to assess reasons for non-compliance and motivate compliance.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experimental referral procedure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly detailed in the abstract)
Number of subjects: 0
Study: 2361812

Group type: EXPERIMENTAL
Intervention: Diet (D)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Diet-Exercise (DE)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Exercise (EX)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Non-exercising subjects (from D and DE)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Diet (D) and Diet-Exercise (DE)
Number of subjects: 44
Study: 369652

Group type: EXPERIMENTAL
Intervention: Tienilic acid 250 mg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Bendrofluazide 5 mg
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Spironolactone 100 mg
Number of subjects: 13

Group type: COMPARATOR
Intervention: All three drugs
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Bendrofluazide and Tienilic acid
Number of subjects: 13

Group type: COMPARATOR
Intervention: Other two agents (Bendrofluazide and Spironolactone)
Number of subjects: 13
Study: 31208509

Group type: EXPERIMENTAL
Intervention: High-dose caffeine (10 mg/kg maintenance dose after 20 mg/kg loading dose)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Low-dose caffeine (5 mg/kg maintenance dose after 20 mg/kg loading dose)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: High-dose caffeine
Number of subjects: 78
Study: 28221719

Group type: EXPERIMENTAL
Intervention: Bouncing
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Assisted Autogenic Drainage (AAD)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Bouncing combined with AAD (BAAD)
Number of subjects: 150
Study: 26731724

Group type: EXPERIMENTAL
Intervention: Temsirolimus (25mg weekly IV infusions)
Number of subjects: 44
Study: 25086478

Group type: EXPERIMENTAL
Intervention: Resorbable screws (Inion CPS)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Titanium screws (Stryker)
Number of subjects: 101
Study: 22000411

Group type: EXPERIMENTAL
Intervention: Arthroscopic rotator cuff repair with a transtendon technique (group I)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Arthroscopic rotator cuff repairs after tear completion (group II)
Number of subjects: 48
Study: 19321228

Group type: EXPERIMENTAL
Intervention: CPR+AED
Number of subjects: 993

Group type: COMPARATOR
Intervention: CPR only
Number of subjects: 993
Study: 17552372

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 201
Study: 17122357

Group type: EXPERIMENTAL
Intervention: Intranasal leptin delivery; superpotent leptin-receptor agonists; manipulation of SOCS-3, PTP-1B, ciliary neurotrophic factor; traditional interventions for weight loss.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Activation of melanocortin receptors; activation of 5-HT2C and 5-HT1B receptors.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhibition of neuropeptide Y, melanin-concentrating hormone, ghrelin, and endocannabinoids.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modulation of gastrointestinal satiation and hunger signals.
Number of subjects: 0
Study: 12218750

Group type: EXPERIMENTAL
Intervention: Shoe with high material hardness
Number of subjects: 6

Group type: COMPARATOR
Intervention: Shoe with low material hardness
Number of subjects: 6
Study: 10543929

Group type: EXPERIMENTAL
Intervention: Inogatran (low molecular mass direct thrombin inhibitor)
Number of subjects: 1209

Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 1209
Study: 7843899

Group type: EXPERIMENTAL
Intervention: Higher levels of beta-carotene in serum
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Higher levels of alpha-carotene, beta-cryptoxanthin, and lutein in serum
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Higher levels of carotenoids and alpha-tocopherol
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Overall serum levels of carotenoids and tocopherols
Number of subjects: 400
Study: 2201795

Group type: EXPERIMENTAL
Intervention: High dose (100 million units) recombinant alpha‐2b‐interferon
Number of subjects: 87

Group type: COMPARATOR
Intervention: Low dose (10 million units) recombinant alpha‐2b‐interferon
Number of subjects: 87
Study: 189334

Group type: EXPERIMENTAL
Intervention: 30 mg ACTH 4-10
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 15 mg ACTH 4-10
Number of subjects: 24

Group type: COMPARATOR
Intervention: matched placebo
Number of subjects: 24
Study: 31974857

Group type: EXPERIMENTAL
Intervention: 10:4 training group (10 s work bouts with 4 min of rest, n=11)
Number of subjects: 42

Group type: COMPARATOR
Intervention: CON (control group, n=10)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 10:2 training group (10 s work bouts with 2 min of rest, n=11)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 30:4 training group (30 s work bouts with 4 min of rest, n=10)
Number of subjects: 42
Study: 31288177

Group type: EXPERIMENTAL
Intervention: VEGF-A165/bFGF plasmid (VIF) administered via electromechanical system NOGA-guided intramyocardial injections into ischemic regions.
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo plasmid injections.
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both groups (VIF and Placebo).
Number of subjects: 52
Study: 28374466

Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA) - 156 ml of a mixture of 0.2% ropivacaine + 30 mg ketorolac + 0.5 mg (5 ml) adrenaline
Number of subjects: 59

Group type: COMPARATOR
Intervention: Saline and intravenous ketorolac (Control)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA)
Number of subjects: 59